Company news
Awakn Life Sciences Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CSE Bulletin: Delist - Awakn Life Sciences Corp. (AWKN)
May 27, 2025
Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc
May 27, 2025
Awakn Life Sciences Announces Shareholder Approval of Arrangement
April 23, 2025
Awakn Life Sciences Provides Supplemental Disclosure in Connection with Proposed Plan of Arrangement
April 11, 2025
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc
February 27, 2025
Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD
January 27, 2025
Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder
January 20, 2025
Awakn Life Sciences Announces Credit Facility
December 18, 2024
Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc
December 16, 2024
Awakn Announces Promising Results from Aminoindane New Chemical Entity Pre-Clinical Program
December 10, 2024
Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites
October 22, 2024
Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program
October 15, 2024
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program
October 4, 2024
Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing
September 18, 2024
Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program
August 28, 2024
Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder
August 9, 2024
Awakn Life Sciences Announces Closing of Tranche of Private Placement and Warrant Extension
July 31, 2024
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio
July 22, 2024
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC
July 18, 2024
Awakn Life Sciences Announces Closing of Tranche of Private Placement
June 4, 2024
CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)
May 31, 2024
CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ
May 8, 2024
Awakn Life Sciences Discusses Filing of Financial Statements
May 2, 2024
Awakn Life Sciences Announces Closing of Tranche of Private Placement
April 17, 2024
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic
April 3, 2024
CSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN)
February 12, 2024
Awakn Life Sciences Announces Listing on the Canadian Securities Exchange
February 12, 2024